Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sepsis | 22 | 2021 | 3517 | 2.61 | Why? |
| Intestinal Mucosa | 5 | 2017 | 1046 | 1.60 | Why? |
| Multiple Organ Failure | 3 | 2017 | 1724 | 0.94 | Why? |
| Gastrointestinal Microbiome | 4 | 2019 | 1961 | 0.90 | Why? |
| Herpesviridae Infections | 1 | 2021 | 172 | 0.77 | Why? |
| Guanylate Cyclase | 1 | 2018 | 10 | 0.77 | Why? |
| Conflict of Interest | 2 | 2018 | 175 | 0.75 | Why? |
| Critical Care | 11 | 2021 | 14081 | 0.72 | Why? |
| Myosin-Light-Chain Kinase | 1 | 2017 | 2 | 0.72 | Why? |
| Hospital Design and Construction | 1 | 2020 | 287 | 0.69 | Why? |
| Hospitals, Isolation | 1 | 2020 | 300 | 0.66 | Why? |
| Research | 3 | 2021 | 2115 | 0.66 | Why? |
| Endotoxemia | 1 | 2018 | 143 | 0.64 | Why? |
| Pseudomonas Infections | 1 | 2021 | 425 | 0.64 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.63 | Why? |
| Physician Assistants | 1 | 2017 | 115 | 0.61 | Why? |
| Heat-Shock Proteins | 1 | 2018 | 226 | 0.60 | Why? |
| Enterocytes | 1 | 2017 | 245 | 0.58 | Why? |
| Nurse Practitioners | 1 | 2017 | 248 | 0.52 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.50 | Why? |
| Shock, Septic | 4 | 2018 | 1313 | 0.47 | Why? |
| El Salvador | 2 | 2021 | 27 | 0.46 | Why? |
| Interferon-gamma | 2 | 2019 | 2711 | 0.45 | Why? |
| Intestines | 1 | 2017 | 817 | 0.43 | Why? |
| Drug Industry | 1 | 2018 | 689 | 0.41 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.40 | Why? |
| CD4-Positive T-Lymphocytes | 7 | 2019 | 4545 | 0.39 | Why? |
| Signaling Lymphocytic Activation Molecule Family | 2 | 2019 | 22 | 0.38 | Why? |
| Apoptosis | 3 | 2019 | 2335 | 0.37 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.37 | Why? |
| Intensive Care Units | 9 | 2022 | 29594 | 0.34 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.34 | Why? |
| Fluid Therapy | 4 | 2018 | 628 | 0.31 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.30 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.26 | Why? |
| Mice | 10 | 2021 | 21357 | 0.25 | Why? |
| Societies, Medical | 2 | 2018 | 6907 | 0.24 | Why? |
| Gammaherpesvirinae | 1 | 2021 | 10 | 0.24 | Why? |
| Critical Illness | 8 | 2022 | 17281 | 0.24 | Why? |
| Central America | 1 | 2021 | 86 | 0.22 | Why? |
| Stress, Mechanical | 1 | 2021 | 143 | 0.22 | Why? |
| Gene Knockout Techniques | 2 | 2018 | 347 | 0.21 | Why? |
| Interleukin-27 | 1 | 2019 | 10 | 0.21 | Why? |
| Animals | 15 | 2021 | 78931 | 0.20 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.20 | Why? |
| Peyer's Patches | 1 | 2019 | 27 | 0.20 | Why? |
| Leukosialin | 1 | 2018 | 1 | 0.20 | Why? |
| Peritoneum | 1 | 2018 | 54 | 0.19 | Why? |
| Academic Medical Centers | 4 | 2022 | 3088 | 0.19 | Why? |
| Health Care Coalitions | 1 | 2018 | 14 | 0.18 | Why? |
| Disease Models, Animal | 6 | 2019 | 10998 | 0.18 | Why? |
| Systems Integration | 1 | 2018 | 72 | 0.18 | Why? |
| Interleukin-33 | 1 | 2019 | 120 | 0.18 | Why? |
| Tight Junction Proteins | 1 | 2017 | 16 | 0.18 | Why? |
| Mice, Knockout | 3 | 2019 | 1815 | 0.18 | Why? |
| Microbiota | 2 | 2019 | 1240 | 0.17 | Why? |
| Receptors, CXCR4 | 1 | 2017 | 83 | 0.17 | Why? |
| Molecular Chaperones | 1 | 2018 | 124 | 0.17 | Why? |
| Internship, Nonmedical | 1 | 2017 | 30 | 0.17 | Why? |
| Bacterial Translocation | 1 | 2017 | 39 | 0.17 | Why? |
| Vasoconstrictor Agents | 2 | 2018 | 714 | 0.16 | Why? |
| Nutritional Support | 2 | 2018 | 447 | 0.16 | Why? |
| Rodentia | 1 | 2018 | 235 | 0.16 | Why? |
| Permeability | 1 | 2017 | 238 | 0.16 | Why? |
| Pseudomonas aeruginosa | 1 | 2021 | 652 | 0.16 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2018 | 265 | 0.15 | Why? |
| Lymphocyte Subsets | 2 | 2017 | 987 | 0.15 | Why? |
| B7-H1 Antigen | 1 | 2019 | 541 | 0.15 | Why? |
| Accreditation | 1 | 2017 | 203 | 0.15 | Why? |
| Teaching Rounds | 1 | 2018 | 208 | 0.15 | Why? |
| Death | 1 | 2018 | 334 | 0.14 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.14 | Why? |
| Plasmapheresis | 1 | 2018 | 437 | 0.14 | Why? |
| Interleukin-17 | 1 | 2019 | 602 | 0.14 | Why? |
| CD8-Positive T-Lymphocytes | 4 | 2019 | 5837 | 0.14 | Why? |
| Hospitals, Public | 1 | 2020 | 774 | 0.14 | Why? |
| Spleen | 1 | 2018 | 877 | 0.13 | Why? |
| Disclosure | 1 | 2018 | 423 | 0.13 | Why? |
| Metabolic Diseases | 1 | 2019 | 505 | 0.13 | Why? |
| Immunomodulation | 2 | 2019 | 1472 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Immunologic Memory | 3 | 2019 | 3362 | 0.12 | Why? |
| Evidence-Based Medicine | 3 | 2021 | 3228 | 0.11 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.11 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.10 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Practice Guidelines as Topic | 4 | 2021 | 15421 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.09 | Why? |
| Humans | 29 | 2022 | 930598 | 0.09 | Why? |
| Anti-Bacterial Agents | 4 | 2018 | 10083 | 0.09 | Why? |
| B7-2 Antigen | 1 | 2007 | 56 | 0.09 | Why? |
| National Institutes of Health (U.S.) | 2 | 2021 | 443 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.09 | Why? |
| CD40 Antigens | 1 | 2007 | 118 | 0.08 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2007 | 146 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Respiration, Artificial | 4 | 2020 | 22116 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Feces | 1 | 2019 | 4235 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.06 | Why? |
| Male | 12 | 2022 | 367725 | 0.06 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.06 | Why? |
| Surgeons | 1 | 2017 | 2233 | 0.06 | Why? |
| Antigens, CD | 1 | 2007 | 984 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2019 | 6670 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Pediatrics | 1 | 2017 | 2969 | 0.05 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.05 | Why? |
| United States | 5 | 2021 | 46150 | 0.05 | Why? |
| Hospital Mortality | 2 | 2022 | 22087 | 0.05 | Why? |
| Female | 10 | 2022 | 380317 | 0.05 | Why? |
| Receptors, CXCR | 1 | 2018 | 8 | 0.05 | Why? |
| Hyaluronan Receptors | 1 | 2019 | 61 | 0.05 | Why? |
| Listeriosis | 1 | 2019 | 36 | 0.05 | Why? |
| Flow Cytometry | 2 | 2018 | 2393 | 0.05 | Why? |
| Listeria monocytogenes | 1 | 2019 | 68 | 0.05 | Why? |
| Nutritional Physiological Phenomena | 1 | 2019 | 100 | 0.05 | Why? |
| Cost Control | 1 | 2018 | 35 | 0.04 | Why? |
| Time | 1 | 2020 | 631 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Stakeholder Participation | 1 | 2021 | 481 | 0.04 | Why? |
| Georgia | 1 | 2020 | 955 | 0.04 | Why? |
| Cell Death | 1 | 2019 | 536 | 0.04 | Why? |
| Energy Intake | 1 | 2019 | 323 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2021 | 657 | 0.04 | Why? |
| Interinstitutional Relations | 1 | 2018 | 170 | 0.04 | Why? |
| CD4 Antigens | 1 | 2017 | 306 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Hospitalists | 1 | 2017 | 109 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Health Occupations | 1 | 2018 | 235 | 0.04 | Why? |
| Reimbursement Mechanisms | 1 | 2018 | 243 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Staff Development | 1 | 2018 | 222 | 0.04 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.04 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.03 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.03 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2021 | 1013 | 0.03 | Why? |
| Ventilation | 1 | 2021 | 1145 | 0.03 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.03 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.03 | Why? |
| Hemodynamics | 1 | 2021 | 1562 | 0.03 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.03 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.03 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Drug Approval | 1 | 2021 | 1325 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.03 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.03 | Why? |
| Hospitalization | 1 | 2022 | 54280 | 0.03 | Why? |
| Intersectoral Collaboration | 1 | 2018 | 1065 | 0.03 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.02 | Why? |
| Cohort Studies | 2 | 2022 | 36005 | 0.02 | Why? |
| Cytokines | 2 | 2019 | 15010 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2019 | 4002 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Lectins, C-Type | 1 | 2007 | 405 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Immunophenotyping | 1 | 2007 | 1290 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.01 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.01 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Time Factors | 1 | 2022 | 31397 | 0.01 | Why? |
| Middle Aged | 3 | 2022 | 270681 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 9335 | 0.01 | Why? |
| Adult | 3 | 2020 | 244371 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Lymphocyte Count | 1 | 2007 | 4758 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Aged | 2 | 2022 | 215776 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.01 | Why? |
Coopersmith's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(157)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_